Liver Cancer Risk After Hepatitis C Treatment in HIV Patients

People with HIV and severe liver damage face a significant risk of liver cancer even after successfully treating hepatitis C with direct-acting antivirals (DAAs). This finding highlights the importance of ongoing monitoring for liver cancer in these patients. The study focused on individuals with HIV who had advanced liver fibrosis or cirrhosis. These conditions make the liver more susceptible to cancer. Even after curing hepatitis C, the risk of liver cancer remains high in this group. Direct-acting antivirals have revolutionized the treatment of hepatitis C. They offer a cure for most patients. However, the cure does not eliminate the risk of liver cancer for those with existing severe liver damage. Regular check-ups are crucial for early detection of liver cancer. This can improve outcomes and save lives. Patients and doctors should be aware of this risk and take appropriate measures. The findings underscore the need for continued vigilance. Even after successful treatment, the journey to health is not over. Ongoing care and monitoring are essential for long-term well-being.